These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 25665273)
1. Buprenorphine: a new player in neonatal withdrawal syndrome. Nanda S; Brant R; Regier M; Yossuck P W V Med J; 2015; 111(1):16-21. PubMed ID: 25665273 [TBL] [Abstract][Full Text] [Related]
2. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication. Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926 [TBL] [Abstract][Full Text] [Related]
3. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Kakko J; Heilig M; Sarman I Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989 [TBL] [Abstract][Full Text] [Related]
4. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study. Bakstad B; Sarfi M; Welle-Strand GK; Ravndal E Eur Addict Res; 2009; 15(3):128-34. PubMed ID: 19332991 [TBL] [Abstract][Full Text] [Related]
5. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome. Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839 [TBL] [Abstract][Full Text] [Related]
6. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome. Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415 [TBL] [Abstract][Full Text] [Related]
7. [Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases]. Lejeune C; Aubisson S; Simmat-Durand L; Cneude F; Piquet M; Gourarier L; Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():21-7. PubMed ID: 11965095 [TBL] [Abstract][Full Text] [Related]
8. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates. Gaalema DE; Scott TL; Heil SH; Coyle MG; Kaltenbach K; Badger GJ; Arria AM; Stine SM; Martin PR; Jones HE Addiction; 2012 Nov; 107 Suppl 1(0 1):53-62. PubMed ID: 23106927 [TBL] [Abstract][Full Text] [Related]
9. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. O'Connor AB; Collett A; Alto WA; O'Brien LM J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660 [TBL] [Abstract][Full Text] [Related]
10. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?]. Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044 [TBL] [Abstract][Full Text] [Related]
11. Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy? O'Connor AB; O'Brien L; Alto WA J Perinat Med; 2013 Sep; 41(5):621-3. PubMed ID: 23612625 [TBL] [Abstract][Full Text] [Related]
12. Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Welle-Strand GK; Skurtveit S; Jansson LM; Bakstad B; Bjarkø L; Ravndal E Acta Paediatr; 2013 Nov; 102(11):1060-6. PubMed ID: 23909865 [TBL] [Abstract][Full Text] [Related]
13. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome. Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042 [TBL] [Abstract][Full Text] [Related]
14. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy. Liu AJ; Jones MP; Murray H; Cook CM; Nanan R Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243 [TBL] [Abstract][Full Text] [Related]
15. A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome. Hall ES; Isemann BT; Wexelblatt SL; Meinzen-Derr J; Wiles JR; Harvey S; Akinbi HT J Pediatr; 2016 Mar; 170():39-44.e1. PubMed ID: 26703873 [TBL] [Abstract][Full Text] [Related]
16. Neonatal neurobehavior effects following buprenorphine versus methadone exposure. Coyle MG; Salisbury AL; Lester BM; Jones HE; Lin H; Graf-Rohrmeister K; Fischer G Addiction; 2012 Nov; 107 Suppl 1(0 1):63-73. PubMed ID: 23106928 [TBL] [Abstract][Full Text] [Related]
17. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates. Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769 [TBL] [Abstract][Full Text] [Related]
18. Adverse neonatal outcomes associated with maternal severe mental health diagnoses and opioid use. Ma J; Sahasranaman V; Kirby RS; Boaz T J Perinatol; 2020 Oct; 40(10):1497-1505. PubMed ID: 32753708 [TBL] [Abstract][Full Text] [Related]
19. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939 [TBL] [Abstract][Full Text] [Related]